# US 2003/0207258 A1 · Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0207258 A1
- Document ID: US20030207258A1
- Status: Published application
- Kind: A1
- Application number: 10/139,025
- Filed: 2002-05-03
- Published: 2003-11-06
- Earliest claimed: 2002-05-03
- Assignees: Kimberly-Clark Worldwide, Inc.
- Inventors: David Cohen; Rosann Kaylor
- Web page: https://patentgrep.com/patent/US20030207258A1

## CPC

- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A biosensor includes a substrate member with a pattern of active areas of receptive material and a pattern of blocking material layers. The receptive material and blocking material are attached to the substrate member with a photo-reactive crosslinking agent activated in a masking process. The receptive material is specific for an analyte of interest.

## Claims

### Claim 1

A biosensor, comprising:
a substrate member;
a layer containing a photo-reactive crosslinking agent applied to said substrate member;
a pattern of active receptive material areas defined on said substrate by attachment with said crosslinking agent, said receptive material comprising molecules specific for an analyte of interest;
a pattern of inactive blocking material areas defined on said substrate by attachment with said crosslinking agent, said inactive blocking material areas being interposed with said active receptive material areas and being non-reactive with the analyte of interest;
said active receptive material and inactive blocking material areas defined on said substrate by a masking process wherein a mask is placed over said substrate member prior to irradiating said substrate member with an energy source sufficient for activating said photo-reactive crosslinking agent such that areas exposed by said mask define one of said active receptive material and inactive blocking material areas, and said areas shielded by said mask define the other of said blocking material and receptive material areas; and
wherein when said biosensor is exposed to a medium containing said analyte of interest, the analyte binds to said receptive material in said active areas and subsequently facilitate diffraction of transmitted or reflected light in a diffraction pattern corresponding to said active receptive material areas.

### Claim 2 (depends on 1)

The biosensor as in claim 1, wherein said substrate comprises a material from the list of materials consisting of plastics, metal coated plastics and glass, functionalized plastics and glass, silicon wafers, glass, and foils.

### Claim 3 (depends on 1)

The biosensor as in claim 1, wherein said substrate member comprises a polymer film coated with a metal.

### Claim 4 (depends on 3)

The biosensor as in claim 3, wherein said polymer film comprises polyethylene-terephthalate.

### Claim 5 (depends on 3)

The biosensor as in claim 3, wherein said metal is selected from the group consisting of gold, silver, chromium, nickel, platinum, aluminum, iron, copper, gold oxide, chromium oxide, titanium, titanium oxide, silicone nitride, silver oxide, or zirconium.

### Claim 6 (depends on 1)

The biosensor as in claim 1, wherein said diffraction pattern is visible to the naked eye.

### Claim 7 (depends on 1)

The biosensor as in claim 1-,-wherein said receptive material is protein based.

### Claim 8 (depends on 7)

The biosensor as in claim 7, wherein said receptive material is an antibody.

### Claim 9 (depends on 1)

The biosensor as in claim 1, wherein said substrate member is irradiated with UV light at a wavelength sufficient for activating said photo-reactive crosslinking agent exposed through said mask.

### Claim 10 (depends on 1)

The biosensor as in claim 1, wherein said receptive material is at least one of antigens, antibodies, nucleotides, chelators, enzymes, bacteria, yeasts, fungi, viruses, bacterial pili, bacterial flagellar materials, nucleic acids, polysaccharides, lipids, proteins, carbohydrates, metals, hormones, peptides, aptamers and respective receptors for said materials.

### Claim 11 (depends on 1)

The biosensor as in claim 1, wherein said analyte of interest is at least one of a bacteria, yeast, fungus, virus, rheumatoid factor, IgG, IgM, IgA, IgD and IgE antibodies, carcinoembryonic antigen, streptococcus Group A antigen, viral antigens, antigens associated with autoimmune disease, allergens, tumor antigens, streptococcus group B antigen, HIV I or HIV II antigen, antibodies viruses, antigens specific to RSV, an antibody, antigen, enzyme, hormone, polysaccharide, protein, lipid, carbohydrate, drug, nucleic acid, Neisseria meningitides groups A, B, C, Y and W sub 135, Streptococcus pneumoniae, E. coli K1, Haemophilus influenza type A/B, an antigen derived from microorganisms, PSA and CRP antigens, a hapten, a drug of abuse, a therapeutic drug, an environmental agents, or antigens specific to Hepatitis.

### Claim 12 (depends on 1)

The biosensor as in claim 1, wherein said photo-reactive crosslinking agent comprises one of SANPAH (N-Succinimidyl 2-[p-azidosalicylamido] ethyl-1, 3′-dithiiopropionate); SAND (Sulfosuccinimidyl 2-[mazido-o-nitro-benzamido] ethyl-1, 3′-dithiopropionate); and ANB-NOS (N-5-Azido-2-nitrobenzoyloxysuccinimide).

### Claim 13 (depends on 1)

The biosensor as in claim 1, wherein said blocking material comprises a material that is non-reactive with the analyte of interest.

### Claim 14 (depends on 1)

The biosensor as in claim 1, wherein said pattern of active receptive material areas corresponds to said exposed areas of said mask, and said pattern of inactive blocking material areas corresponds to said shielded areas of said mask.

### Claim 15

A method of making a biosensor, comprising the steps of:
applying a photo-reactive crosslinking agent to a surface of a substrate member;
forming one of a receptive material layer and a blocking material layer over the crosslinking agent;
placing a mask over the substrate member, the mask having a configuration so as to shield at least one underlying area of the substrate member while exposing at least one adjacent area, and irradiating the substrate member and mask combination with an energy source sufficient to activate the crosslinking agent in the areas exposed by the mask, the activated crosslinking agent crosslinking with the respective receptive material or blocking material in the exposed areas;
cleaning the unreacted receptive material or blocking material from the shielded areas of the substrate member after removal of the mask;
forming a layer of the respective other of the blocking material and receptive material over the surface of the substrate member, and irradiating the substrate member with the energy source so as to activate the remaining crosslinking agent in the previously shielded areas, the activated crosslinking agent crosslinking with the respective blocking material or receptive material; and
wherein a resulting pattern of active receptive material areas and blocking material areas are defined according to the pattern of shielded and exposed areas of the mask.

### Claim 16 (depends on 15)

The method as in claim 15, comprising forming the receptive material layer on the substrate before the blocking material layer such that the pattern of active areas of receptive material correspond to the exposed areas of the mask.

### Claim 17 (depends on 15)

The method as in claim 15, comprising selecting the substrate member from the group of materials consisting of plastics, metal coated plastics and glass, functionalized plastics and glass, silicon wafers, glass, and foils.

### Claim 18 (depends on 15)

The method as in claim 15, wherein the substrate member comprises a polymer film coated with a metal.

### Claim 19 (depends on 18)

The method as in claim 18, comprising selecting the metal from the group consisting of gold, silver, chromium, nickel, platinum, aluminum, iron, copper, gold oxide, chromium oxide, titanium, titanium oxide, silicone, silicone oxide, silicone nitride, silver oxide, or zirconium.

### Claim 20 (depends on 15)

The method as in claim 15, wherein the receptive material in the active areas facilitates diffraction of transmitted or reflected light in a diffraction pattern corresponding to the active receptive material areas, and further comprising viewing the diffraction pattern of active areas of receptive material with the naked eye.

### Claim 21 (depends on 15)

The method as in claim 15, wherein the receptive material is protein based.

### Claim 22 (depends on 20)

The method as in claim 20, wherein the receptive material is an antibody.

### Claim 23 (depends on 15)

The method as in claim 15, comprising irradiating the substrate member with UV light at a wavelength sufficient for activating the photo-reactive crosslinking agent exposed through the mask.

### Claim 24 (depends on 15)

The method as in claim 15, comprising selecting the receptive material from at least one of antigens, antibodies, nucleotides, chelators, enzymes, bacteria, yeasts, fungi, viruses, bacterial pili, bacterial flagellar materials, nucleic acids, polysaccharides, lipids, proteins, carbohydrates, metals, hormones, peptides, aptamers and respective receptors for said materials.

### Claim 25 (depends on 15)

The method as in claim 15, wherein the analyte of interest is selected from at least one of a bacteria, yeast, fungus, virus, rheumatoid factor, IgG, IgM, IgA, IgD and IgE antibodies, carcinoembryonic antigen, streptococcus Group A antigen, viral antigens, antigens associated with autoimmune disease, allergens, tumor antigens, streptococcus group B antigen, HIV I or HIV II antigen, antibodies viruses, antigens specific to RSV, an antibody, antigen, enzyme, hormone, polysaccharide, protein, lipid, carbohydrate, drug, nucleic acid, Neisseria meningitides groups A, B, C, Y and W sub 135, Streptococcus pneumoniae, E. coli K1, Haemophilus influenza type A/B, an antigen derived from microorganisms, PSA and CRP antigens, a hapten, a drug of abuse, a therapeutic drug, an environmental agents, or antigens specific to Hepatitis.

### Claim 26 (depends on 15)

The method as in claim 15, wherein the photo-reactive crosslinking agent is one of SANPAH (N-Succinimidyl 2-[p-azido-salicylamido] ethyl-1, 3′-dithiiopropionate); SAND (Sulfosuccinimidyl 2-[m-azido-o-nitrobenzamido] ethyl-1, 3′-dithiopropionate); and ANB-NOS (N-5-Azido-2-nitrobenzoyloxysuccinimide).
